P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.

P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.

Bibliographic Details
Main Authors: Jozef Michalka, Jana Marková, Ľubica Gahérová, Mária Maco, Vít Procházka, Jan Kořen, Alice Sýkorová, Pavla Štěpánková, Kateřina Steinerová, Lekaa Mohammad, Juraj Ďuraš, Barbora Velacková, Tomáš Doležal, Kateřina Benešová, Marie Lukášová, Andrea Janíková, Zdeněk. Král., Heidi Móciková
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000890984.54786.aa

Internet

http://journals.lww.com/10.1097/01.HS9.0000890984.54786.aa

Similar Items